“The simplSEQ workflow offers many workflow advantages over other methods of cell-free DNA extraction especially speed, simplicity, reproducibility, which are
Blog
Company Filed Second Patent Application to Extend Core Technology Applications
Murrieta Genomics is pleased to announce that U.S. Patent and Trademark
Murrieta Genomics, the launch pad for genomic sequencing startups, is pleased to announce that simplSEQ, an incubator company and subsidiary,
“Our first product is a kit for the purification and isolation of nucleic acids from plasma that we believe will
Press Releases
Murrieta Genomics, LLC, the Southern California genomic sequencing business incubator, will be represented at the World Precision Medicine Congress 2018
Murrieta Genomics’ First Incubator Company Presenting at World Health Care Congress in Washington DC
Murrieta Genomics, LLC, the Southern California genomic sequencing business incubator, will see its first incubator company debut at one of
Blog
“The simplSEQ workflow offers many workflow advantages over other methods of cell-free DNA extraction especially speed, simplicity, reproducibility, which are
Company Filed Second Patent Application to Extend Core Technology Applications
Murrieta Genomics is pleased to announce that U.S. Patent and Trademark
Murrieta Genomics, the launch pad for genomic sequencing startups, is pleased to announce that simplSEQ, an incubator company and subsidiary,
“Our first product is a kit for the purification and isolation of nucleic acids from plasma that we believe will
Press Releases
Murrieta Genomics, LLC, the Southern California genomic sequencing business incubator, will be represented at the World Precision Medicine Congress 2018
Murrieta Genomics’ First Incubator Company Presenting at World Health Care Congress in Washington DC
Murrieta Genomics, LLC, the Southern California genomic sequencing business incubator, will see its first incubator company debut at one of